FDA clearance for ‘revolutionary’ approach to J-Pouch issue
ExeGi Pharma LLC, which develops live biotherapeutic drugs and probiotics, says the FDA has cleared…
January 27, 2023 - 2 minutes
News and Trends
Orbsen Therapeutics happy with interim diabetic kidney disease study results
Orbsen Therapeutics Limited has announced what it says are encouraging headline interim results from the…
January 26, 2023 - 3 minutes
New tool to fight antibiotic resistance
The World Health Organization (WHO) ranks antibiotic resistance as one of the top 10 threats…
January 26, 2023 - 5 minutes
Lupus treatment hope from Japanese miRNA research
A group of researchers from the Graduate School of Medicine at Nagoya University in Japan…
January 26, 2023 - 5 minutes
First patient treated in Atrogi type 2 diabetes clinical study
Atrogi AB, an early-stage Swedish pharma company, has announced that the first patient has been…
January 26, 2023 - 2 minutes
Sysnav and Roche partner on movement tracking technology
Sysnav Healthcare and Roche have partnered to develop industry standard outcome measurements in diseases associated…
January 26, 2023 - 2 minutes
Ibex to collaborate with AstraZeneca and Daiichi Sankyo on AI breast cancer product
Ibex Medical Analytics has announced an agreement with AstraZeneca and Daiichi Sankyo, for the development,…
January 26, 2023 - 3 minutes
Milestone for gene-edited therapy for sickle cell disease
Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics have announced that the European Medicines Agency (EMA) has…
January 26, 2023 - 3 minutes
Alcohol-related liver disease: mechanism could lead to new therapies
Alcohol-related liver disease is among the most common causes of morbidity and mortality worldwide. Due…
January 24, 2023 - 3 minutes
First leukemia patient dosed with SMART101
Smart Immune has announced that the first adult leukemia patient has been dosed with SMART101,…
January 24, 2023 - 2 minutes
Ubiquigent and University of Glasgow to collaborate on drug discovery
Ubiquigent Limited, a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new…
January 24, 2023 - 3 minutes
Funding for university to develop new motor neuron disease therapies
Medical research charity LifeArc, the Motor Neurone Disease Association (MND Association) and the My Name’5…
January 24, 2023 - 4 minutes
